Archive - Gary Schwitzer's HealthNewsReview Substack

Keeping an eye on the Kennedy capers

A continuing feature tracking the turmoil left in his wake

Jul 14 •

Elephants, jellyfish & memory pill advertising

In the supplement-supportive environment of the Trump administration, consumers will need to be especially attentive to advertising claims made about …

Jul 7 •

Social Security email was confusing, inaccurate and cheerleading

Many of you probably received this email from the Social Security Administration this past week.

Jul 6 •

I’m prey for predatory journals & conferences

If I’m getting invites, imagine who else is

Jul 2 •

The Gobbledygook of “Gold Standard Science”

An executive order heaping with hypocrisy

Jul 1 •

June 2025

Pipeline of supplements flows from federal health agencies

Long promotional track records of Kennedy, Oz, and both Surgeon General nominees

Jun 30 •

Mistrust in artificial intelligence in health care - 6 items

Here’s another one of my collections of readings on a given topic.

Jun 25 •

Focus on GLP-1 drugs & eye problems

I’m following a number of problems associated with GLP-1 drugs for overweight, obesity or Type 2 diabetes.

Jun 24 •

New Alzheimer's test: The coverage vs. context

When the FDA recently approved the Lumipulse blood test to help with diagnose of Alzheimer’s Disease, there was the usual roundup of hyperbole which can…

Jun 23 •

Bernie wants drug ads banned. He's not alone.

Two independent US Senators, Bernie Sanders and Angus King, have introduced the End Prescription Drug Ads Now Act that would ban prescription drug ads…

Jun 17 •

Weighing more GLP-1 drug concerns

Update on patients quitting, costs, access

Jun 16 •

Too much glitz, too little evidence, in full body scan stories

How new screening tests get free and glowing publicity

Jun 11 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts